Biography

Dr Matthew Brooks completed his medical training at The University of Melbourne, followed by specialist cardiology and interventional training at The Royal Melbourne Hospital. He undertook two further fellowships at the Royal Infirmary of Edinburgh and Copenhagen University Hospital, with a focus on structural heart disease intervention and complex percutaneous coronary intervention. He is a consultant cardiologist at The Royal Melbourne Hospital and also practices at Melbourne Private and John Fawkner Private Hospitals.

Dr Brooks’ expertise is in complex percutaneous coronary artery intervention including chronic total occlusions, left main PCI and rotational atherectomy. He has a special interest in structural heart disease intervention including transcatheter aortic valve replacement and mitral valve repair/replacement, percutaneous left atrial appendage closure, device closure of interatrial defects, and paravalvular leak closure.

In 2019 at The Royal Melbourne Hospital, Dr Brooks broke new ground performing the first BASILICA operation in Australia. The surgery uses a technique developed in the USA that prevents coronary artery obstruction, a rare but often fatal complication during transcatheter aortic valve implantation (TAVI).

Procedures & Conditions

Procedures Performed
  • Transcatheter Aortic Valve Implantation (TAVI)
  • Structural Heart Disease Intervention and Complex
  • Percutaneous Coronary Artery Intervention In Particular Chronic Total Occlusion (CTO)
  • Left Atrial Appendage Closure Device
  • Mitral Valve Repair
Conditions Treated
  • Aortic Stenosis
  • Coronary Artery Disease
  • Acute Coronary Syndrome
  • Ischaemic Heart Disease
  • Myocardial Infarction
  • Angina Pectoris
  • Mitral Valve Disease

Experience

  • Clinical Fellow In Interventional Cardiology                                                          
    The Royal Infirmary of Edinburgh, Scotland 2015-16
  • Clinical Fellow in Structural and Adult Congenital Heart Disease Intervention
    Copenhagen University Hospital, Denmark 2014-15
  • Clinical Fellow In Interventional Cardiology          
    The Royal Melbourne Hospital 2012-14

Awards

Awards
  • 2004

    Deans Honour List Final Year

Research & Publications

Publications

1. Fuchs A, De Backer O, Brooks M, et al. Subclinical leaflet thickening and stent frame geometry in self expanding transcatheter heart valves. Er Intervention. 2017 Oct 12;13(9)

2. Sondergaard L, Brooks M, Ihlemann N, Jonsson A, Holme S, Tang M, Terp K, Quadri A. Transcatheter mitral valve implantation via transapical approach: an early experience. Eur J Cardiothorac Surg. 2015 Feb 3. De Backer O, Arnous S, Sandholt B, Brooks M, Biasco L, Franzen O, Loon L, Bech B, Sondergaard L. Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation. Am J Cardiol. 2015 Apr 15;115(8):1123-9.

3. De Backer O, Arnous S, Lonborg J, Brooks M, Biasco L, Jonsson A, Franzen OW, Sondergaard L. Recovery from anaemia in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation – prevalence, predictors and clinical outcomes. PLoS One. 2014 Dec 1;9(12).

4. Brennan AL, Andrianopoulos N, Duffy SJ, Reid CM, Clark DJ, Loane P, New G, Black A, Yan BP, Brooks M, Roberts L, Carroll EA, Lefkovits J, Ajani AE. Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspective. Intern Med J. 2014 May;44(5):471-7.

5. Brooks MJ, Andrews DT. Molecular mechanisms of ischemic conditioning: translation into patient outcomes. Future Cardiol. 2013 Jul;9(4):549-68.

6. Brooks MJ, Hannan LM, Ng A, Irving LB, Aggarwal A. An unusual cause of transient ischaemic attack. Can Respir J. 2013 May-Jun;20(3):150.

7. Brooks MJ, Grigg L, Mitchell P, Iyer R, Zentner D, Ng A, Gurvitch R. Percutaneous closure of a giant saphenous vein graft aneurysm using an Amplatzer vascular plug. JACC Cardiovasc Interv. 2013 Apr;6(4):420-2.

8. Brooks MJ, Pattison DA, Teo EP, Price S, Gurvitch R. Amiodarone induced destructive thyroiditis associated with coronary artery vasospasm and recurrent ventricular fibrillation. Eur Thyroid J. 2013;2:65-7.

9. Brooks MJ, Joshi SB, Grigg L. Ruptured giant major aortopulmonary collateral artery. Eur Heart J. 2013 Jun;34(23):1766.

10. Brooks MJ, Iyer R. Coronary arteritis. N Engl J Med. 2012 Aug 16;367(7):658.

11. Brooks MJ, Royse C, Eisen D, Sparks P, Bhagwat K, Royse A. An accidental mass. Lancet 2011 May 21;377(9779):1806.

12. Bhagwat K, Hallam J, Shivanand G, Brooks MJ, Atkinson V, Goldblatt J. Expanding cardiac pseudotumor. J Thorac Cardiovasc Surg 2011 Jun;141(6):e41–2.

View More

Videos

Aortic stenosis: risk factors, symptoms, and diagnostic tests
Treatment options of aortic stenosis, balloon valvuloplasty & TAVI
The benefits and risks of TAVI